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Abstract  
Nanomaterial-based field-effect transistor (FET) sensors are capable of label-free real-time 
chemical and biological detection with high sensitivity and spatial resolution, although direct 
measurements in high ionic strength physiological solutions remain challenging due to the Debye 
screening effect. Recently, we demonstrated a general strategy to overcome this challenge by 
incorporating a biomolecule-permeable polymer layer on the surface of silicon nanowire FET 
sensors. The permeable polymer layer can increase the effective screening length immediately 
adjacent to the device surface and thereby enable real-time detection of biomolecules in high 
ionic strength solutions. Here, we describe studies demonstrating both the generality of this 
concept and application to specific protein detection using graphene FET sensors.  
Concentration-dependent measurements made with polyethylene glycol (PEG) modified 
graphene devices exhibited real-time reversible detection of prostate specific antigen (PSA) from 
1 to 1000 nM in 100 mM phosphate buffer. In addition, co-modification of graphene devices 
with PEG and DNA aptamers yielded specific irreversible binding and detection of PSA in pH 
7.4 1x phosphate buffered saline (PBS) solutions, whereas control experiments with proteins that 
do not bind to the aptamer showed smaller reversible signals. In addition, the active aptamer 
receptor of the modified graphene devices could be regenerated to yield multi-use selective PSA 
sensing under physiological conditions. The current work presents an important concept toward 
the application of nanomaterial-based FET sensors for biochemical sensing in physiological 
environments and thus could lead to powerful new tools for basic research and healthcare. 
Significance 
Nanoelectronic transistor sensors based on synthesized one- and two-dimensional nanomaterials 
have achieved real-time label-free detection of a wide-range of biological species with high 
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sensitivity, although direct analysis of biological samples has been limited due to Debye charge 
screening in physiological solutions. This paper describes a general strategy overcoming this 
challenge involving co-modification of the transistor sensor surface with a polymer and receptor, 
where the polymer forms a permeable layer that increases the effective screening length and 
receptor enables selective detection of analytes. The capability of this strategy was demonstrated 
with selective detection of cancer markers in physiological solution, thus opening substantial 
opportunities for real-time sensing applications in biology and medicine. 
 
Keywords: Field-effect-transistor / Debye screening / surface modification / DNA aptamer 
receptor / polyethylene glycol (PEG)  
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\body 
Nanoelectronic biosensors offer broad capabilities for label-free high-sensitivity real-time 
detection of biological species that are important to both fundamental research and biomedical 
applications (1-6).  In particular, FET biosensors configured from semiconducting nanowires (1, 
2), single-walled carbon nanotubes (1, 3, 4) and graphene (1, 5, 6) have been extensively 
investigated since the first report of real-time protein detection using silicon nanowire devices 
(7). Subsequent studies have demonstrated highly-sensitive and in some cases multiplexed 
detection of key analytes, including protein disease markers (8-10), nucleic acids (11-13), and 
viruses (14), as well as detection of protein-protein interactions (8, 15-17) and enzymatic activity 
(8).   
The success achieved with nanomaterial-based FET biosensors has been limited primarily 
to measurements in relatively low ionic strength non-physiological solutions due to the Debye-
screening length (18, 19). In short, the screening length in physiological solutions, <1 nm, 
reduces the field produced by charged macromolecules at the FET surface and thus makes real-
time label-free detection difficult. The first method reported to overcome this intrinsic limitation 
of FET biosensors involved desalting to enable subsequent low ionic strength detection (8, 20), 
although this also precludes true real-time measurements. Truncated antibody receptors (21) and 
small aptamers (22) also have been used to reduce the distance between target species and the 
FET surfaces, although the generality of such methods for real-time sensing in physiological 
conditions requires further study. In addition, recent work has shown that high-frequency 
mixing-based detection can be used to overcome Debye screening effects (23, 24), although the 
device geometry may limit this approach in cellular and in vivo applications.  
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Recently, we have developed a strategy to overcome the Debye screening limitation that 
involves modification of a FET sensor surface with a biomolecule-permeable polymer layer to 
increase the effective screening length in the region immediately adjacent to the device, and 
demonstrated this concept for nonspecific detection of PSA using silicon nanowire sensors in 
physiological solutions (25). To explore the generality of this approach for nanomaterials-based 
FET sensors and further extend the concept to selective analyte recognition and detection, we 
herein describe studies demonstrating controlled nonspecific and highly-selective protein 
detection in physiological media using graphene FET sensors in which the device surfaces are 
modified only with a biomolecule-permeable polymer layer and co-modified with DNA 
aptamer/biomolecule-permeable polymer layer, respectively.   
Results and Discussion 
To realize the biodetection in physiological solutions, a biomolecule-permeable polymer layer 
was constructed by surface modification as illustrated in Fig. 1A (see Materials and Methods). 
This modification strategy involves (i) adsorption of pyrene butyric acid (PYCOOH) via π-π 
stacking to introduce functional carboxyl groups on the graphene surface (26, 27), followed by 
(ii) covalent co-coupling of amine-terminated 10 kDa polyethylene glycol (PEG) and either the 
spacer molecule ethanolamine (ETA) or a DNA aptamer as a specific protein receptor. The 
coupling procedure (see Materials and Methods; (28) uses 1-ethyl-3-[3-
dimethylaminopropyl]carbodiimide hydrochloride (EDC) and N-hydroxysulfosuccinimide 
(Sulfo-NHS) to couple PEG/ETA and PEG/aptamer to the carboxyl groups of PYCOOH-
modified graphene device surfaces. 
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Our sensor chip (Fig. 1B) consists of a FET array with nominally 180 individually 
addressable graphene devices (see Fig. S1 for full device layout), and was fabricated as follows. 
First, graphene was synthesized using chemical vapor deposition (CVD) and transferred onto the 
SiO2 surface of a Si device fabrication wafer (29). Second, the graphene FET channels were 
defined by photolithography, and then passivated metal source/drain contacts were fabricated by 
a second photolithography step, metal thermal evaporation, and sputtered Si3N4 (see Materials 
and Methods). Completed device chips were attached and wire-bonded to standard PCB-boards 
for interfacing to measurement electronics, and a poly(dimethylsiloxane) (PDMS) microfluidic 
channel was mounted over the central device region for delivery of analyte solutions using a 
syringe pump (Fig. 1B; see Materials and Methods). An optical image (Fig. 1C) shows two types 
of graphene channels with dimensions of 5×5 μm and 5×10 μm sharing the common source (S) 
with individually addressable drain (D) contacts. 
The properties of functionalized graphene and graphene devices were characterized by 
several complimentary methods prior to carrying out sensing measurements. First, atomic force 
microscopy (AFM) studies of PEG-modified graphene devices carried out in 1x PBS (Fig. 2A, 
see Materials and Methods) show a well-defined 6-8 nm step between the PEG-modified 
graphene FET channel and the SiO2/Si substrate. Similar AFM measurements on unmodified 
graphene devices, which show a 0.7-1 nm step, and Raman mapping (see Supplementary text 
and Fig. S2) are consistent with monolayer graphene (30, 31). These data indicate that the 
thickness of the PEG layer on the graphene devices is ca. 5-7 nm, which is consistent with 
previous indentation measurements of PEG layers carried out by AFM (32). In addition, the 
AFM measurements show that the PEG layer was only observed on graphene, indicating that the 
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PYCOOH initial modification was specific only to the graphene devices as expected (27), and 
thus allows for selective functionalization of the graphene sensor surfaces.  
Second, device electrical measurements (Fig. 2B-D) highlight several additional points 
relevant to graphene FET sensors. Conductance versus water-gate voltage data obtained from the 
same graphene device during sequential modification steps (Fig. 2B; see Materials and Methods) 
shows that the charge neutrality point (CNP) of bare graphene device 0.51 V, increases to 0.60 V 
and then decreases to 0.25 V after PYCOOH and PEG modification, respectively. CNP 
measurements recorded from 46 devices during the sequential modification steps (Fig. 2C) 
yielded average ± 1SD values of 0.55 ± 0.08, 0.62 ± 0.07 and 0.22 ± 0.06 for bare, PYCOOH-
modified and PEG-modified devices, respectively. These values suggest that the bare graphene 
was initially p-doped, and that PEG-modification leads to n-doping of the devices (33). This 
overall doping effect was confirmed by Raman spectroscopy mapping (see Supplementary text 
and Fig. S2), which showed a 1594 to 1585 cm-1 G band shift in bare to PEG-modified graphene. 
Last, the PEG layer on graphene devices yielded a statistically significant drop (p < 0.001, 
double-sided t-test) of the transconductance, from 228 ± 65 µS/V before modification to 119 ± 
64 µS/V after completion of the PEG modification (Fig. 2D). These results are consistent with 
previous observations for PEG-modified silicon nanowire FETs (25), and moreover, an estimate 
of the effective dielectric constant of the PEG layer (see Supplementary text) supports the 
hypothesis that this permeable layer reduces the effective dielectric constant at sensor surface 
compared to aqueous solution. 
Initial PSA sensing measurements carried out with ETA and a 1:4 PEG:ETA modified 
graphene devices in pH 6 phosphate buffer (PB) as a function of solution ionic strength (Fig. 3A) 
exhibited substantial differences for detection of fixed concentration PSA (pI = 6.8 – 7.5; (34, 
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35). First, measurements made on ETA-modified graphene devices exhibit an easily detected 
signal at 10 mM PB that rapidly drops to near baseline at 50 mM (black trace, Fig. 3A and Fig. 
S3). No detectable PSA response was observed in 100 mM PB, which has a ∼0.7 nm Debye 
length (25) comparable with physiological solution. In contrast, PEG/ETA-modified devices 
show only a gradual decrease in PSA sensing signal with increasing PB concentration. The 
signal response in 100 mM PB, ca. 14 mV, exceeds the signal recorded from ETA-modified 
devices in 10 mM PB, and moreover, well-defined sensing signals, ca. 11 mV, can still be 
recorded in 150 mM PB where the Debye length is ∼0.5 nm (25). In addition, these data show 
that PSA sensing is reversible with the device conductance returning to baseline following 
addition of pure PB buffer, thus establishing that there is minimal irreversible protein binding to 
the modified graphene devices.  
Protein concentration-dependent sensing experiments carried out on PEG/ETA-modified 
devices in 100 mM PB (Fig. 3B) demonstrate sensing responses for PSA concentrations from 1 
to 1000 nM. A plot of the calibrated sensing signal versus [PSA] recorded simultaneously from 
three independent devices (Fig. 3C) yields a response varying rapidly at low PSA concentration 
and then saturating at higher concentrations. Replotting the data as function of log[PSA] (inset, 
Fig. 3C) defines a relatively linear detection regime 10 ≤ [PSA] ≤ 500 nM. In addition, the 
concentration dependent sensing data was fit using a Langmuir model (36): 
ܵ = ܵ௠௔௫ × ௞×େଵା௞×େ                                              (1) 
where S and Smax represent the signal and saturation signal, respectively, in response to PSA 
concentration C, and k is an equilibrium constant. The fit, which has a correlation coefficient of 
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0.949, yields a value of k, 7.9× 106 M−1, that is similar to our previous result for concentration-
dependent PSA sensing on PEG-modified silicon nanowire sensor (25). 
We have also investigated the sensor response for different ionic strength solutions as a 
function of the PEG:ETA ratio used to modify graphene device surfaces. A summary of results 
obtained from devices modified with PEG:ETA ratios of 1:2, 1:4, 1:6 and 1:8 (Fig. 3D) 
demonstrates that graphene devices with 1:4 PEG:ETA modification ratio have the highest 
sensitivities with signal amplitudes of 21.3 ± 1.1, 13.7 ± 0.5 and 11.0 ± 0.9 mV in 50, 100 and 
150 mM PB, respectively. The sensitivity of devices decreased significantly at higher and lower 
modification ratios. We hypothesize that the ratio between PEG and the spacer molecule ETA 
can control the permeability in the PEG layer in terms of dielectric properties and target 
molecule translocation, although future studies will be needed to determine unambiguously the 
origin of these results.  
Last, we have investigated specific detection of PSA using graphene devices co-modified 
with PEG and a DNA aptamer for PSA (see Materials and Methods). The DNA aptamer is 
advantageous as the receptor for several reasons, including (i) the conformational changes of 
highly-charged aptamer upon protein binding (37, 38) can result in a significant change in 
electric field near the sensor surface even if the solution pH is close to the protein pI, and (ii) the 
aptamer can be denatured and refolded multiple times without loss of activity (39, 40) for 
multiple experiments. All experiments were carried out in pH 7.4 1x PBS containing 2 mM Mg2+, 
where the added Mg2+ helps to maintain the active aptamer conformation before and after 
regeneration (39, 41).  Notably, sensing experiments carried out with 1:2 PEG:aptamer co-
modified graphene FET devices (blue curve, Fig. 4A) showed a well-defined 5.2 mV irreversible 
response to 300 nM PSA, which contrasts the response of the PEG/ETA control device (black 
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curve, Fig. 4A) that exhibited no measurable response. The absence of obvious response in the 
control device is consistent with the fact that these specific sensing experiments are carried out at 
physiological pH (vs. pH 6 in Fig. 3), which is close to (vs. lower than) the pI of PSA (34). In 
control experiments carried out with pure aptamer-modified devices (red curve, Fig. 4A) showed 
a ca. 1.2 mV irreversible response. This latter sensor response is almost 5-times smaller obtained 
with the 1:2 PEG:aptamer modified devices, and thus supports the importance of the PEG layer 
for increasing the effective Debye length and sensitivity of the co-modified graphene FET 
sensors. 
Given the strong aptamer/PSA binding we have investigated regeneration of the active 
receptor by denaturing the aptamer with guanidinium chloride (42). For example, following 
initial detection of 100 nM PSA, (black curve, Fig. 4B, 4C) devices were treated with 6 M 
guanidinium chloride for 10 minutes and then washed in the pH 7.4 buffer. Subsequent detection 
of the same concentration PSA with the same devices (red curve, Fig. 4B, 4C) showed equivalent 
sensing signal and confirmed that the functional aptamer was regenerated. In addition, we note 
that the amplitude of these signals, ca. 2.3 mV, is approximately 2-times smaller than the higher 
concentration PSA measurement in Fig. 4A, indicating the potential for concentration-dependent 
detection. Finally, following a second cycle of regeneration, the data in Fig. 4C shows that the 
device with carcinoembryonic antigen (CEA), which does not bind specifically to the aptamer, 
yielded a small (near baseline) ~ 0.5 mV reversible binding signal (blue curve, Fig. 4C) in 
contrast to the irreversible 5-times larger signal obtained for PSA at the same concentration. 
Together these results show the capability to achieve specific real-time detection of proteins in 
physiological solution in competition with other proteins. 
Conclusions 
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We have demonstrated a general strategy to enable direct FET sensing measurements in high 
ionic strength physiological solutions that involves co-modification of device surfaces with PEG 
and spacer molecules or PEG and aptamer receptors. Concentration-dependent measurements 
made with PEG/ETA-modified graphene FET devices exhibited real-time reversible detection of 
PSA from 1 to 1000 nM in 100 mM PB, which has a screening length comparable to 
physiological solutions, and further showed that detection was possible even at 150 mM PB. In 
addition, studies carried out using PEG/DNA aptamer modified graphene devices showed 
irreversible specific binding and detection of PSA in pH 7.4 1x PBS solutions, whereas control 
experiments with CEA protein, which does not bind specifically to the aptamer, showed smaller 
reversible signals. In addition, the active aptamer receptor of the modified graphene devices 
could be regenerated to yield multi-use selective PSA sensing under these physiological 
conditions. We believe this work represents a critical step toward general application of 
nanomaterial-based FET sensors in many areas, including in vitro and in vivo real-time chip-
based monitoring of disease marker proteins, which could have substantial impact on both 
fundamental research and healthcare, as well as integration in free-standing nanoelectronic 
scaffolds for engineered tissues  and in vivo implants (43).  
 
Materials and Methods 
Graphene synthesis. Monolayer graphene was synthesized on 25 μm thick Cu foil (Alfa Aesar, 
Tewksbury, MA) via a reported low-pressure CVD method (29). Before growth, the Cu foil was 
electropolished in phosphoric acid (85 wt%) and ethylene glycol (15 wt%) for 30 min and rinsed 
in DI water. The polished Cu foil was loaded into a 1-inch quartz tube furnace, annealed in 40 
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sccm H2 during the 40 min room temperature to 1000 ºC heating process, followed by an 20 min 
anneal at 1000 ºC. Graphene growth was initiated by introducing 5 sccm methane into furnace, 
and growth was continued for 30 min. 
FET sensor fabrication. Graphene films were transferred onto Si wafer using a reported 
poly(methyl methacrylate) (PMMA) method (29), where PMMA (PMMA-C5, Microchem Corp., 
Newton, MA) was spin-coated on as-grown graphene/Cu foil, at 2000 rpm for 1 min, the Cu foil 
was etched in ammonium persulfate aqueous solution (10 wt%), the floating PMMA/graphene 
film was rinsed in DI water, and then transferred to the SiO2 surface of Si/SiO2 target wafer. 
PMMA was dissolved in acetone at 70 ºC.  
The graphene was patterned using photolithography. (i) LOR 3A (Microchem Corp., Newton, 
MA) was spin-coated onto graphene/Si wafer, at 4000 rpm for 1 min, followed by 180 ºC baking 
for 2 min. S1805 (Microchem Corp., Newton, MA) was spin-coated on the wafer at 4000 rpm for 
1 min, followed by 1 min of 115 ºC baking. (ii) Graphene channels were defined by 
photolithography. (iii) After developing in CD-26 (Microchem Corp., Newton, MA) for 1 min, 
the graphene/Si wafer was placed into an O2 plasma cleaner (Fetmo, Diener electronic GmbH + 
Co., Germany) to etch graphene in regions without photoresist protection. (iv) Photoresist on the 
graphene/Si wafer was removed in Remover PG (Microchem Corp., Newton, MA). (v) The 
patterned graphene was further cleaned by vacuum thermal annealing at 300 ºC for 1 hour 
(Jipelec rapid thermal processor, SEMCO Technologies, France) to reduce PMMA residue (44). 
Device fabrication was completed by combination of photolithography with metal and Si3N4 
deposition. (i) LOR 3A (Microchem Corp., Newton, MA) was spin-coated onto graphene/Si 
wafer, at 4000 rpm for 1 min, followed by 180 ºC baking for 2 min. S1805 (Microchem Corp., 
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Newton, MA) was subsequently coated on top, at 4000 rpm for 1 min, followed by 1 min 115 ºC 
baking. (ii) Metal contacts were defined using photolithography. (iii) After developing in CD-26 
for 1 min, 10 nm Cr/65 nm Au/3 nm Cr were deposited via thermal evaporation, with deposition 
rates of 0.2 Å/s, 2.0 Å/s and 1 Å/s, respectively. (iv) A 30 nm Si3N4 passivation layer was 
deposited over the metal contacts via magnetron sputtering (Orion 3, AJA international Inc., 
Scituate, MA). 
Electrical characterization. Devices chips were wire-bonded to a PCB interface board as 
shown in Fig. 1B, and then a PDMS microfluidic channel was mounted on the sensor chip with 
the channel aligned with the central region of the device chip where the graphene FETs are 
located. Polyethylene tubing was attached to the inlet and the outlet holes on the PDMS 
microfluidic channel, and buffer or protein/buffer solutions were drawn through the channel 
using a syringe pump. 
Water-gate versus conductance measurements were carried out in 1x PBS using a home-made 
probe station. The water-gate was varied at 100 mV/s sweep rate while monitoring the graphene 
FET conductance for a fixed 100 mV source/drain voltage; the FET conductance was amplified 
(1211; DL Instruments, LLC, Ithaca, NY). The resulting conductance versus water-gate curves 
are used to calculate CNP and transconductance values for the devices. 
Depending on the integrity of transferred graphene film, the yield of working sensors (showing 
water-gate response) calculated based on all of 180 available source/drain electrodes on each 
sensor chip was usually above 95%. 
AFM characterization. The device chip was mounted in an airtight chamber, before being 
immersed in a droplet of 1x PBS, and measurements were carried out at room temperature using 
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an AFM (MFP-3D Coax AFM, Oxford Instruments Asylum Research, Inc., Santa Barbara, CA). 
A Si AFM tip (AC160TS-R3-35, Oxford Instruments Asylum Research, Inc., Santa Barbara, CA) 
was used to acquire both AFM height and amplitude images of graphene channel, under constant 
amplitude tapping (AC) mode.  
Surface modification. The device chip was soaked in 0.6 mM 1-pyrenebutyric acid (PYCOOH, 
Sigma-Aldrich, St Louis, MO) in dimethylformamide (DMF, Sigma-Aldrich, St Louis, MO) 
solution for an hour. After washing with DMF 3 times, the device chip was immersed in pure 
DMF for 1 hour at 60 °C with agitation to further remove excess PYCOOH. Then, the device 
chip was modified with ethanolamine (ETA, 411000, Sigma-Aldrich, St Louis, MO), pure 
aptamer, the mixture of 10 kDa PEG (PSB-267, Creative PEGWorks, NC) and ETA, or PEG and 
aptamer (5’-NH2-C6-TTTTTAATTAAAGCTCGCCATCAAATAGCTTT-3’, Gene Link, NY) 
using 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC, 03449, Sigma-
Aldrich, St Louis, MO) and N-hydroxysulfosuccinimide sodium salt (56485, Sigma-Aldrich, St 
Louis, MO) cross-linkers (28). For the ETA and PEG/ETA modified graphene devices, the 
functionalization was carried out in a petri dish on a shaker for 2 hours, followed by rinsing with 
DI water. For pure aptamer and PEG/aptamer and the corresponding ETA/PEG (control) 
modified graphene devices, the functionalization was conducted in the PDMS microfluidic 
channel for 1.5 hours, followed by rinsing with pH 7.4 1x PBS buffer containing 2 mM Mg2+.  
Aptamer regeneration. To release PSA and regenerate the aptamer receptors, the device chip 
was incubated with 6 M guanidinium chloride (G3272, Sigma-Aldrich, St Louis, MO) for 10 
minutes, followed by DI water wash and then PBS (containing 2 mM Mg2+) buffer to 
reconstitute the functional conformation of PSA aptamers. 
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Sensing measurements. Measurements were carried out using up to 3 independent lock-in 
amplifiers (SR830, Stanford Research Systems, Inc. Sunnyvale, CA) with 30 mV modulation 
amplitudes and modulation frequencies of 79, 97, and 103 Hz to simultaneously record 3 
graphene devices selected from 180 devices on the chip. A Ag/AgCl electrode was used as a 
reference; sensing experiments were all carried out in the linear regime, which in some cases 
required a DC offset of the water-gate/reference voltage. The conductance versus time data were 
digitized and recorded on computer using custom software. The water-gate responses of devices 
were characterized before PSA detection experiments, and device transconductance values were 
determined from the water-gate data. Graphene FET signals were converted to absolute millivolt 
(mV) values for the calibrated sensing signals using the device transconductance determined 
from these water-gate measurements. 
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Figure Legends 
Figure 1. Active sensor surface and sensor chip. (A) Illustration of a graphene FET device 
with co-modification of PEG and a small molecule spacer or PEG and a receptor, for nonspecific 
and specific detection of the analyte, respectively. Dark purple: Silicon wafer, light blue: 600 nm 
SiO2, black: graphene, yellow: metal contact, light purple: Si3N4 passivation layer, red oval: PY-
COOH, green: spacer molecule, blue: PEG chain, red star: analyte. EDC and Sulfo-NHS serve as 
crosslinkers to couple PYCOOH with PEG and spacer molecules. (B) Optical image of a typical 
device chip (central green square) mounted on a PCB interface board that is plugged into the 
input/output interface connected to a computer controlled data acquisition system. The copper 
squares surrounding the device chip are connected to the chip by wire-bonding. A PDMS 
microfluidic channel is mounted onto the central graphene region. The inlet/outlet of solution 
was controlled with a syringe pump via tubing. Scale bar: 1 cm. (C) Bright-field microscopy 
image of two types of graphene channels with dimensions of 5×5 μm and 5×10 μm, sharing the 
common source (S) with individually addressable drain (D) contacts. The white dashed rectangle 
highlights one graphene FET. Scale bar: 20 μm.  
 
Figure 2. Characterizations of modified graphene surfaces. (A) AFM image shows a ~ 6-8 
nm PEG layer in 1x PBS on the graphene FET channel with respect to the SiO2/Si substrate. 
Scale bar: 1 μm. (B) Conductance versus water-gate voltage data recorded from a typical device 
(source/drain voltage = 100 mV) in 1x PBS before and after sequential modification steps: bare 
graphene (red), and PY-COOH- (green) and PEG-modified graphene (blue). (C) Box plots of 
CNPs on 46 bare graphene (red), 46 PY-COOH-modified (green) and 37 PEG-modified 
graphene devices (blue). (D) Box plots of the transconductance before and after PY-COOH 
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(green) and PEG (blue) modifications. The highest and lowest horizontal lines in the boxes in (C) 
and (D) represent the standard deviation, while the middle line represents the mean value. The 
vertical whiskers show the maximum and minimum values. 
 
Figure 3. Nonspecific PSA detection in high ionic strength solutions. (A) PB concentration-
dependent PSA signal amplitude versus time data recorded from ETA-modified (control) and 
ETA/PEG-modified devices. The black trace represents the response of the ETA-modified 
devices. The PSA concentration in all experiments shown in (A) was 100 nM. (B) Time-
dependent signal response traces at different PSA concentrations for a PEG-modified graphene 
FET sensor in 100 mM PB. (C) Plot of the sensor response versus PSA concentration. The red 
line is fit of the data with Langmuir adsorption isotherm with k = 7.9 × 106 M−1. The inset shows 
the sensor response (mV) versus logarithm of the PSA concentration. The PEG: ETA 
modification ration in A, B and C was 1:4. (D) Signal amplitude dependence on the ratio between 
PEG and ETA in the modification layer. All experiments were carried out below the PSA 
isoelectric point in pH 6 PB. The error bars in (C) and (D) represent the standard deviation from 
three independent devices on the same device chip.  
 
Figure 4. Specific PSA detection in high ionic strength solutions. (A) 300 nM PSA responses 
from 1:2 PEG:ETA-, pure aptamer- and 1:2 PEG :aptamer-modified graphene FET devices. (B) 
A device with 1:2 PEG:aptamer modification shows consistent response to 100 nM PSA before 
and after 6 M guanidinium chloride regeneration for 10 minutes. (C)  A device (distinct from B) 
with 1:2 PEG: aptamer modification first shows consistent response to 100 nM PSA before and 
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after regeneration, and then shows a weaker and reversible response to 100 nM CEA. All 
experiments were carried out in pH 7.4 1x PBS containing 2mM Mg2+. 




